Six month assessment of low dose rituximab in the treatment of rheumatoid arthritis during coronavirus disease 2019 (COVID-19) pandemic
Publication date: Available online 6 May 2021Source: The Egyptian RheumatologistAuthor(s): Yunus Durmaz, Ilker Ilhanli
Source: The Egyptian Rheumatologist - Category: Rheumatology Source Type: research
More News: Arthritis | Coronavirus | COVID-19 | Egypt Health | Pandemics | Rheumatoid Arthritis | Rheumatology | Rituxan